1 | 1279184 | Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet. | J Natl Cancer Inst | 1992 Nov 4 |
4 |
2 | 1279244 | High incidence of nuclear accumulation of p53 protein in gastric cancer. | Jpn J Clin Oncol | 1992 Aug |
3 |
3 | 1280773 | Altered structure and expression of the p53 gene in human neuroepithelial tumors. | Neurol Med Chir (Tokyo) | 1992 Sep |
2 |
4 | 1295480 | Immunohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: influence on metastasis-free survival. | Anticancer Res | 1992 Nov-Dec |
1 |
5 | 1303002 | [The role of p53 gene in the switch of U937 leukemic cells from growth into differentiation]. | Shi Yan Sheng Wu Xue Bao | 1992 Dec |
3 |
6 | 1310637 | Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates. | Cancer Res | 1992 Feb 15 |
4 |
7 | 1317462 | Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. | J Natl Cancer Inst | 1992 Jun 3 |
2 |
8 | 1319835 | Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. | Cancer Res | 1992 Jul 15 |
2 |
9 | 1322785 | p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. | Cancer Res | 1992 Aug 15 |
2 |
10 | 1322917 | Elevation of large-T antigen production by sodium butyrate treatment of SV40-transformed WI-38 fibroblasts. | J Cell Biochem | 1992 May |
5 |
11 | 1324739 | Cell and molecular biology of gastrointestinal tract cancer. | Curr Opin Oncol | 1992 Aug |
1 |
12 | 1324804 | Autocrine motility factor and its receptor: role in cell locomotion and metastasis. | Cancer Metastasis Rev | 1992 Mar |
1 |
13 | 1330291 | p53 gene mutation spectrum in hepatocellular carcinoma. | Cancer Res | 1992 Nov 15 |
1 |
14 | 1330867 | Overexpression of p53: a rare event in a large series of white patients with hepatocellular carcinoma. | Hepatology | 1992 Nov |
1 |
15 | 1332185 | Tumours of the liver. | Scand J Gastroenterol Suppl | 1992 |
5 |
16 | 1332921 | Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. | Hepatology | 1992 Dec |
1 |
17 | 1347094 | Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. | Lancet | 1992 Mar 7 |
2 |
18 | 1347900 | p53 codon 249ser mutations in hepatocellular carcinoma patients with low aflatoxin exposure. | Lancet | 1992 Apr 4 |
1 |
19 | 1352359 | Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. | J Natl Cancer Inst | 1992 Jul 15 |
1 |
20 | 1358781 | Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression. | Hum Pathol | 1992 Nov |
3 |
21 | 1370482 | Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. | J Biol Chem | 1992 Jan 25 |
1 |
22 | 1382834 | Co-ordinate expression of c-fos, p53 and cytokeratin genes during the alteration of growth of human hepatoma cells. mRNA levels measured by reverse transcription and polymerase chain reaction. | Cancer Lett | 1992 Sep 30 |
2 |
23 | 1384667 | Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. | Genes Chromosomes Cancer | 1992 Jul |
1 |
24 | 1391801 | Alterations of the p53 gene in Philadelphia chromosome-positive leukemia including chronic myelogenous leukemia and acute leukemia. | Int J Hematol | 1992 Aug |
1 |
25 | 1394133 | p53 mutations in breast cancer. | Cancer Res | 1992 Oct 1 |
1 |
26 | 1394191 | Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. | Cancer Res | 1992 Oct 15 |
1 |
27 | 1396069 | [Overexpression of p53 protein in human spontaneous esophageal carcinoma and fetal esophageal carcinoma induced by N-methyl-N-benzylnitrosamine (NMBzA)]. | Zhonghua Zhong Liu Za Zhi | 1992 Jul |
4 |
28 | 1406679 | Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. | Mol Cell Biol | 1992 Nov |
11 |
29 | 1406686 | p53 is covalently linked to 5.8S rRNA. | Mol Cell Biol | 1992 Nov |
12 |
30 | 1408139 | p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. | Oncogene | 1992 Oct |
2 |
31 | 1413493 | Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up. | Virchows Arch A Pathol Anat Histopathol | 1992 |
2 |
32 | 1444195 | Improved immunohistochemical detection of p53 protein in paraffin--embedded tissues reveals elevated levels in most head and neck and lung carcinomas: correlation with clinicopathological parameters. | Anticancer Res | 1992 Sep-Oct |
3 |
33 | 1450522 | Preference of human cdc2 kinase for peptide substrate. | Pept Res | 1992 Sep-Oct |
5 |
34 | 1454521 | Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53. | Nucleic Acids Res | 1992 Nov 11 |
1 |
35 | 1459195 | Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53. | Exp Cell Res | 1992 Dec |
4 |
36 | 1466808 | Conformational effects of selected cancer-related amino acid substitutions in the p53 protein. | J Biomol Struct Dyn | 1992 Oct |
8 |
37 | 1468914 | Overexpression of p53 in head and neck cancer. | Head Neck | 1992 Nov-Dec |
1 |
38 | 1484319 | p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections. | J Pathol | 1992 Dec |
6 |
39 | 1486864 | Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis. | Environ Health Perspect | 1992 Nov |
2 |
40 | 1501881 | Biochemical properties of the growth suppressor/oncoprotein p53. | Oncogene | 1992 Sep |
2 |
41 | 1506270 | Growth inhibition by anchorage-deficiency is associated with increased level but reduced phosphorylation of mutant p53. | Jpn J Cancer Res | 1992 Apr |
6 |
42 | 1510215 | Mutant p53 protein is expressed in Bowen's disease. | Am J Dermatopathol | 1992 Jun |
1 |
43 | 1519662 | In situ hybridization and immunohistochemistry of p53 tumor suppressor gene in human esophageal carcinoma. | Am J Pathol | 1992 Sep |
2 |
44 | 1520594 | Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. | Br J Cancer | 1992 Sep |
1 |
45 | 1525830 | Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. | Cell | 1992 Sep 18 |
1 |
46 | 1528930 | Molecular alterations in human skin tumors. | Prog Clin Biol Res | 1992 |
1 |
47 | 1535157 | Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I. | Proc Natl Acad Sci U S A | 1992 Jun 15 |
1 |
48 | 1540970 | Overexpression and mutation of p53 in endometrial carcinoma. | Cancer Res | 1992 Mar 15 |
1 |
49 | 1545817 | Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae. | Mol Cell Biol | 1992 Mar |
1 |
50 | 1546693 | Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma. | Am J Clin Pathol | 1992 Feb |
3 |